{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T02:59:00Z","timestamp":1781060340893,"version":"3.54.1"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T00:00:00Z","timestamp":1778889600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T00:00:00Z","timestamp":1778889600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s00520-026-10786-9","type":"journal-article","created":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T06:48:34Z","timestamp":1778914114000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["MASCC score and neutropenic complications: what is the likelihood?"],"prefix":"10.1007","volume":"34","author":[{"given":"Mellar P.","family":"Davis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,16]]},"reference":[{"issue":"1","key":"10786_CR1","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1097\/00001648-199701000-00002","volume":"8","author":"KG Moons","year":"1997","unstructured":"Moons KG, van Es GA, Deckers JW et al (1997) Limitations of sensitivity, specificity, likelihood ratio, and Bayes\u2019 theorem in assessing diagnostic probabilities: a clinical example. Epidemiology 8(1):12\u20137","journal-title":"Epidemiology"},{"issue":"3","key":"10786_CR2","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/s0196-0644(98)70352-x","volume":"31","author":"EJ Gallagher","year":"1998","unstructured":"Gallagher EJ (1998) Clinical utility of likelihood ratios. Ann Emerg Med 31(3):391\u2013397. https:\/\/doi.org\/10.1016\/s0196-0644(98)70352-x","journal-title":"Ann Emerg Med"},{"issue":"16","key":"10786_CR3","doi-asserted-by":"publisher","first-page":"3038","DOI":"10.1200\/JCO.2000.18.16.3038","volume":"18","author":"J Klastersky","year":"2000","unstructured":"Klastersky J, Paesmans M, Rubenstein EB et al (2000) The Multinational Association for Supportive Care in Cancer risk index: a multinational scoring system for identifying low-risk febrile neutropenic cancer patients. J Clin Oncol 18(16):3038\u201351. https:\/\/doi.org\/10.1200\/JCO.2000.18.16.3038","journal-title":"J Clin Oncol"},{"issue":"7458","key":"10786_CR4","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1136\/bmj.329.7458.168","volume":"329","author":"JJ Deeks","year":"2004","unstructured":"Deeks JJ, Altman DG (2004) Diagnostic tests 4: likelihood ratios. BMJ 329(7458):168\u2013169. https:\/\/doi.org\/10.1136\/bmj.329.7458.168","journal-title":"BMJ"},{"issue":"8","key":"10786_CR5","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1007\/s00520-004-0614-5","volume":"12","author":"A Uys","year":"2004","unstructured":"Uys A, Rapoport BL, Anderson R (2004) Febrile neutropenia: a prospective study to validate the Multinational Association of Supportive Care of Cancer (MASCC) risk-index score. Support Care Cancer 12(8):555\u2013560. https:\/\/doi.org\/10.1007\/s00520-004-0614-5","journal-title":"Support Care Cancer"},{"issue":"9469","key":"10786_CR6","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1016\/S0140-6736(05)66422-7","volume":"365","author":"DA Grimes","year":"2005","unstructured":"Grimes DA, Schulz KF (2005) Refining clinical diagnosis with likelihood ratios. Lancet 365(9469):1500\u20131505. https:\/\/doi.org\/10.1016\/S0140-6736(05)66422-7","journal-title":"Lancet"},{"issue":"4","key":"10786_CR7","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1111\/j.1651-2227.2006.00179.x","volume":"96","author":"AK Akobeng","year":"2007","unstructured":"Akobeng AK (2007) Understanding diagnostic tests 2: likelihood ratios, pre- and post-test probabilities and their use in clinical practice. Acta Paediatr 96(4):487\u2013491. https:\/\/doi.org\/10.1111\/j.1651-2227.2006.00179.x","journal-title":"Acta Paediatr"},{"issue":"7","key":"10786_CR8","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1007\/s00277-008-0487-7","volume":"87","author":"ND Baskaran","year":"2008","unstructured":"Baskaran ND, Gan GG, Adeeba K (2008) Applying the Multinational Association for Supportive Care in Cancer risk scoring in predicting outcome of febrile neutropenic patients in a cohort of patients. Ann Hematol 87(7):563\u20139. https:\/\/doi.org\/10.1007\/s00277-008-0487-7","journal-title":"Ann Hematol"},{"issue":"8","key":"10786_CR9","doi-asserted-by":"publisher","first-page":"2303","DOI":"10.1007\/s00520-013-1787-6","volume":"21","author":"S Ahn","year":"2013","unstructured":"Ahn S, Lee YS, Lim KS, Lee JL (2013) Adding procalcitonin to the MASCC risk-index score could improve risk stratification of patients with febrile neutropenia. Support Care Cancer 21(8):2303\u20132308. https:\/\/doi.org\/10.1007\/s00520-013-1787-6","journal-title":"Support Care Cancer"},{"key":"10786_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2020.102922","volume":"149","author":"B Zheng","year":"2020","unstructured":"Zheng B, Toarta C, Cheng W et al (2020) Accuracy of the MASCC and CISNE scores for predicting serious complications in adult patients with febrile neutropenia: a systematic review and meta-analysis. Crit Rev Oncol Hematol 149:102922. https:\/\/doi.org\/10.1016\/j.critrevonc.2020.102922","journal-title":"Crit Rev Oncol Hematol"},{"issue":"15","key":"10786_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics15151922","volume":"15","author":"T Kanter","year":"2025","unstructured":"Kanter T, G\u00fcler G (2025) Improving prognostic accuracy of MASCC score with lactate and CRP measurements in febrile neutropenic patients. Diagnostics Basel 15(15):1922. https:\/\/doi.org\/10.3390\/diagnostics15151922","journal-title":"Diagnostics Basel"},{"issue":"2","key":"10786_CR12","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1159\/000546029","volume":"104","author":"Y Nadir","year":"2026","unstructured":"Nadir Y, Kiran P, Erturk D et al (2026) Determining the cut-off value of the MASCC score to predict mortality in hospitalized febrile neutropenic patients: a decade-long single-center retrospective cohort study. Oncology 104(2):167\u2013175. https:\/\/doi.org\/10.1159\/000546029","journal-title":"Oncology"},{"issue":"2","key":"10786_CR13","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-026-10375-w","volume":"34","author":"CE Rivest","year":"2026","unstructured":"Rivest CE, Ben Abderrazik FE, Cote-Marcoux MA et al (2026) Correlation between MASCC score and the evolution of febrile neutropenia in patients with solid tumors: a retrospective study. Support Care Cancer 34(2):141. https:\/\/doi.org\/10.1007\/s00520-026-10375-w","journal-title":"Support Care Cancer"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-026-10786-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-026-10786-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-026-10786-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T02:30:58Z","timestamp":1781058658000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-026-10786-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,16]]},"references-count":13,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["10786"],"URL":"https:\/\/doi.org\/10.1007\/s00520-026-10786-9","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,16]]},"assertion":[{"value":"6 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"546"}}